Cargando…

The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome

OBJECTIVE: The role of the hydroxycarboxylic acid receptor 2 (HCA(2)) in the retinal damage induced by diabetes has never been explored. In this context, the present study highlights an upregulation of retinal HCA(2) receptors in diabetic C57BL6J mice. Moreover, we illustrate that HCA(2) receptors e...

Descripción completa

Detalles Bibliográficos
Autores principales: Trotta, Maria Consiglia, Maisto, Rosa, Guida, Francesca, Boccella, Serena, Luongo, Livio, Balta, Cornel, D’Amico, Giovanbattista, Herman, Hildegard, Hermenean, Anca, Bucolo, Claudio, D’Amico, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338370/
https://www.ncbi.nlm.nih.gov/pubmed/30657794
http://dx.doi.org/10.1371/journal.pone.0211005
_version_ 1783388440984813568
author Trotta, Maria Consiglia
Maisto, Rosa
Guida, Francesca
Boccella, Serena
Luongo, Livio
Balta, Cornel
D’Amico, Giovanbattista
Herman, Hildegard
Hermenean, Anca
Bucolo, Claudio
D’Amico, Michele
author_facet Trotta, Maria Consiglia
Maisto, Rosa
Guida, Francesca
Boccella, Serena
Luongo, Livio
Balta, Cornel
D’Amico, Giovanbattista
Herman, Hildegard
Hermenean, Anca
Bucolo, Claudio
D’Amico, Michele
author_sort Trotta, Maria Consiglia
collection PubMed
description OBJECTIVE: The role of the hydroxycarboxylic acid receptor 2 (HCA(2)) in the retinal damage induced by diabetes has never been explored. In this context, the present study highlights an upregulation of retinal HCA(2) receptors in diabetic C57BL6J mice. Moreover, we illustrate that HCA(2) receptors exert an anti-inflammatory effect on the retinal damage induced by diabetes when activated by the endogenous ligand β-hydroxybutyrate, METHODOLOGY: Seven-to-10-week-old C57BL6J mice were rendered diabetic by a single intraperitoneal injection of streptozotocin (75 mg/kg of body weight) and monitored intermittently over a 10-week period extending from the initial diabetes assessment. Mice with a fasting blood glucose level higher than 250 mg/dl for 2 consecutive weeks after streptozotocin injection were treated twice a week with intraperitoneal injections of 25-50-100 mg/kg β-hydroxybutyrate. RESULTS: Interestingly, while the retinal endoplasmic reticulum stress markers (pPERK, pIRE1, ATF-6α) were elevated in diabetic C57BL6J mice, their levels were significantly reduced by the systemic intraperitoneal treatment with 50 mg/kg and 100 mg/kg β-hydroxybutyrate. These mice also exhibited high NLRP3 inflammasome activity and proinflammatory cytokine levels. In fact, the elevated levels of retinal NLRP3 inflammasome activation markers (NLRP3, ASC, caspase-1) and of the relative proinflammatory cytokines (IL-1β, IL-18) were significantly reduced by 50 mg/kg and 100 mg/kg β-hydroxybutyrate treatment. These doses also reduced the high apoptotic cell number exhibited by the diabetic mice in the retinal outer nuclear layer (ONL) and increased the ONL low connexin 43 expression, leading to an improvement in retinal permeability and homeostasis. CONCLUSIONS: These data suggest that the systemic treatment of diabetic C57BL6J mice with BHB activates retinal HCA(2) and inhibits local damage.
format Online
Article
Text
id pubmed-6338370
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-63383702019-01-30 The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome Trotta, Maria Consiglia Maisto, Rosa Guida, Francesca Boccella, Serena Luongo, Livio Balta, Cornel D’Amico, Giovanbattista Herman, Hildegard Hermenean, Anca Bucolo, Claudio D’Amico, Michele PLoS One Research Article OBJECTIVE: The role of the hydroxycarboxylic acid receptor 2 (HCA(2)) in the retinal damage induced by diabetes has never been explored. In this context, the present study highlights an upregulation of retinal HCA(2) receptors in diabetic C57BL6J mice. Moreover, we illustrate that HCA(2) receptors exert an anti-inflammatory effect on the retinal damage induced by diabetes when activated by the endogenous ligand β-hydroxybutyrate, METHODOLOGY: Seven-to-10-week-old C57BL6J mice were rendered diabetic by a single intraperitoneal injection of streptozotocin (75 mg/kg of body weight) and monitored intermittently over a 10-week period extending from the initial diabetes assessment. Mice with a fasting blood glucose level higher than 250 mg/dl for 2 consecutive weeks after streptozotocin injection were treated twice a week with intraperitoneal injections of 25-50-100 mg/kg β-hydroxybutyrate. RESULTS: Interestingly, while the retinal endoplasmic reticulum stress markers (pPERK, pIRE1, ATF-6α) were elevated in diabetic C57BL6J mice, their levels were significantly reduced by the systemic intraperitoneal treatment with 50 mg/kg and 100 mg/kg β-hydroxybutyrate. These mice also exhibited high NLRP3 inflammasome activity and proinflammatory cytokine levels. In fact, the elevated levels of retinal NLRP3 inflammasome activation markers (NLRP3, ASC, caspase-1) and of the relative proinflammatory cytokines (IL-1β, IL-18) were significantly reduced by 50 mg/kg and 100 mg/kg β-hydroxybutyrate treatment. These doses also reduced the high apoptotic cell number exhibited by the diabetic mice in the retinal outer nuclear layer (ONL) and increased the ONL low connexin 43 expression, leading to an improvement in retinal permeability and homeostasis. CONCLUSIONS: These data suggest that the systemic treatment of diabetic C57BL6J mice with BHB activates retinal HCA(2) and inhibits local damage. Public Library of Science 2019-01-18 /pmc/articles/PMC6338370/ /pubmed/30657794 http://dx.doi.org/10.1371/journal.pone.0211005 Text en © 2019 Trotta et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Trotta, Maria Consiglia
Maisto, Rosa
Guida, Francesca
Boccella, Serena
Luongo, Livio
Balta, Cornel
D’Amico, Giovanbattista
Herman, Hildegard
Hermenean, Anca
Bucolo, Claudio
D’Amico, Michele
The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome
title The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome
title_full The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome
title_fullStr The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome
title_full_unstemmed The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome
title_short The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome
title_sort activation of retinal hca2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the nlrp3 inflammasome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338370/
https://www.ncbi.nlm.nih.gov/pubmed/30657794
http://dx.doi.org/10.1371/journal.pone.0211005
work_keys_str_mv AT trottamariaconsiglia theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT maistorosa theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT guidafrancesca theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT boccellaserena theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT luongolivio theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT baltacornel theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT damicogiovanbattista theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT hermanhildegard theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT hermeneananca theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT bucoloclaudio theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT damicomichele theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT trottamariaconsiglia activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT maistorosa activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT guidafrancesca activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT boccellaserena activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT luongolivio activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT baltacornel activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT damicogiovanbattista activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT hermanhildegard activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT hermeneananca activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT bucoloclaudio activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome
AT damicomichele activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome